These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3154685)

  • 21. Low-molecular-weight heparins in the management of unstable angina.
    Agnelli G; Sonaglia F
    Haemostasis; 2000; 30 Suppl 2():158-67; discussion 146-7. PubMed ID: 11251362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New antithrombotic agents in coronary disease].
    Montalescot G
    Rev Med Interne; 1997; 18(6):450-9. PubMed ID: 9247044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina.
    Goldschmidt-Clermont PJ; Schulman SP; Bray PF; Chandra NC; Grigoryev D; Dise KR; Sagar M; Fox RJ; Coleman LD; Richardson C; Dorsey FC; du Mee C; Kitt MM; Ouyang P; Baughman KL; Gerstenblith G
    Clin Cardiol; 1996 Nov; 19(11):869-74. PubMed ID: 8914780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
    Akkerhuis KM; Neuhaus KL; Wilcox RG; Vahanian A; Boland JL; Hoffmann J; Baardman T; Nehmiz G; Roth U; Klootwijk AP; Deckers JW; Simoons ML;
    Eur Heart J; 2000 Dec; 21(24):2042-55. PubMed ID: 11102255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
    Schulman SP; Goldschmidt-Clermont PJ; Topol EJ; Califf RM; Navetta FI; Willerson JT; Chandra NC; Guerci AD; Ferguson JJ; Harrington RA; Lincoff AM; Yakubov SJ; Bray PF; Bahr RD; Wolfe CL; Yock PG; Anderson HV; Nygaard TW; Mason SJ; Effron MB; Fatterpacker A; Raskin S; Smith J; Brashears L; Gottdiener P; du Mee C; Kitt MM; Gerstenblith G
    Circulation; 1996 Nov; 94(9):2083-9. PubMed ID: 8901655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of thrombolysis versus heparin in unstable angina.
    Schreiber TL; Rizik D; White C; Sharma GV; Cowley M; Macina G; Reddy PS; Kantounis L; Timmis GC; Margulis A
    Circulation; 1992 Nov; 86(5):1407-14. PubMed ID: 1423953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
    Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM
    Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.
    Théroux P; Alexander J; Pharand C; Barr E; Snapinn S; Ghannam AF; Sax FL
    Circulation; 2000 Nov; 102(20):2466-72. PubMed ID: 11076818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options in unstable angina: a clinical update.
    Fox KA; Antman EM
    Eur Heart J; 1998 Sep; 19 Suppl K():K8-10. PubMed ID: 9790283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
    Hamm CW; Heeschen C; Goldmann B; Vahanian A; Adgey J; Miguel CM; Rutsch W; Berger J; Kootstra J; Simoons ML
    N Engl J Med; 1999 May; 340(21):1623-9. PubMed ID: 10341274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
    Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
    Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
    Neri Serneri GG; Gensini GF; Poggesi L; Modesti PA; Rostagno C; Boddi M; Gori AM; Martini F; Ieri A; Margheri M
    Coron Artery Dis; 1994 Feb; 5(2):137-45. PubMed ID: 8180744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.
    Théroux P; Waters D; Qiu S; McCans J; de Guise P; Juneau M
    Circulation; 1993 Nov; 88(5 Pt 1):2045-8. PubMed ID: 8222097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators.
    Yasue H; Ogawa H; Tanaka H; Miyazaki S; Hattori R; Saito M; Ishikawa K; Masuda Y; Yamaguchi T; Motomiya T; Tamura Y
    Am J Cardiol; 1999 May; 83(9):1308-13. PubMed ID: 10235086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
    Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
    Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the quality of care for Medicare beneficiaries admitted to the hospital with unstable angina.
    Krumholz HM; Philbin DM; Wang Y; Vaccarino V; Murillo JE; Therrien ML; Williams J; Radford MJ
    J Am Coll Cardiol; 1998 Apr; 31(5):957-63. PubMed ID: 9561993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.
    Gurfinkel EP; Manos EJ; Mejaíl RI; Cerdá MA; Duronto EA; García CN; Daroca AM; Mautner B
    J Am Coll Cardiol; 1995 Aug; 26(2):313-8. PubMed ID: 7608429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.